Engineers Gate Manager’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,409
Closed -$26.4K 2269
2025
Q1
$26.4K Hold
3,409
﹤0.01% 2073
2024
Q4
$45.1K Hold
3,409
﹤0.01% 2100
2024
Q3
$34K Hold
3,409
﹤0.01% 1998
2024
Q2
$76.1K Buy
3,409
+3
+0.1% +$93 ﹤0.01% 1772
2024
Q1
$200K Buy
3,406
+6
+0.2% +$258 0.01% 1650
2023
Q4
$75.3K Sell
3,400
-99
-3% -$1.49K ﹤0.01% 1805
2023
Q3
$75.5K Sell
3,499
-993
-22% -$39K ﹤0.01% 1622
2023
Q2
$303K Buy
4,492
+3,789
+539% +$1.57M 0.01% 1304
2023
Q1
$328K Buy
+703
New +$372K 0.01% 1202
2022
Q1
Sell
-694
Closed -$245K 1988
2021
Q4
$245K Sell
694
-3,110
-82% -$968K 0.01% 1528
2021
Q3
$972K Buy
+3,804
New +$1.35M 0.06% 500
2021
Q1
Sell
-691
Closed -$641K 1903
2020
Q4
$641K Buy
+691
New +$726K 0.03% 826
2020
Q3
Sell
-248
Closed -$252K 1771
2020
Q2
$252K Sell
248
-20
-7% -$18.6K 0.01% 1310
2020
Q1
$233K Buy
+268
New +$266K 0.02% 1180

Other funds holding KYNB

Engineers Gate Manager's KYNB Position: Q2 2025 in Review

Engineers Gate Manager sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 3,409 shares — an estimated $26.4K sold.

Engineers Gate Manager first reported a position in KYNB in Q1 2020 and held it in 14 quarters. The position peaked at $972K in Q3 2021. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Engineers Gate Manager reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 3,409 Kyntra Bio shares in Q2 2025, an estimated $26.4K.
  • Engineers Gate Manager first reported a position in Kyntra Bio in Q1 2020 and held it in 14 quarters.
  • Engineers Gate Manager's Kyntra Bio position peaked at $972K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Engineers Gate Manager's 13F filing for Q2 2025, filed 14 Aug 2025.